Neoadjuvant Treatments
Showing 1 - 25 of >10,000
Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Mar 6, 2023
Colorectal Cancer Trial (Ezabenlimab, BI 765063, Pembrolizumab)
Recruiting
- Colorectal Cancer
- Ezabenlimab
- +2 more
-
New York, New YorkMount Sinai School of Medicine
Jan 10, 2023
Breast Cancer Trial in Madrid (Vacuum-assisted breast biopsy)
Unknown status
- Breast Cancer
- Vacuum-assisted breast biopsy
-
Madrid, SpainClĂnica Universidad de Navarra
Mar 11, 2021
Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard
Not yet recruiting
- Neoadjuvant Therapy
- standard long-term therapy
- +5 more
- (no location specified)
Apr 22, 2022
Clinical Treatments for Patients With Oropharyngeal Carcinoma
Recruiting
- Oropharynx Carcinoma
- Surgery for early-stage OPC
- +4 more
-
Shanghai, Shanghai, ChinaDepartment of Otorhinolaryngology, Eye & ENT Hospital
Apr 18, 2022
Rectal Carcinoma Trial in France (50 Gy, Capecitabine, 25 Gy)
Completed
- Rectal Carcinoma
- 50 Gy
- +2 more
-
Abbeville, France
- +36 more
Jul 26, 2022
s in Specialized Disease of Laryngeal Carcinoma and
Recruiting
- Glottic Carcinoma
- +5 more
- routines
-
Shanghai, Shanghai, ChinaLei Tao
May 26, 2021
Testing Tumor Tissue and Blood to Help Select Personalized
Not yet recruiting
- NSCLC
- ctDNA, tumor NGS
- (no location specified)
Mar 2, 2021
Surgical Complications and DFS in Obese Rectal Cancer Patients
Recruiting
- Obesity, Morbid
- +2 more
- BIB positioning
-
Naples, ItalyNunzio Velotti
Sep 27, 2023
Pulsed Time-Domain Optical Spectroscopy for Monitoring Responses
Recruiting
- Breast Cancer
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 18, 2019
Colorectal Cancer Stage II, Colorectal Cancer Stage III, Mmr Deficiency Trial in Guangzhou (drug, radiation, procedure, other)
Active, not recruiting
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaMedical Oncology,Sun Yat-sen University Cancer Center
Jan 29, 2023
Surgery After Neoadjuvant Chemotherapy in Locally Advanced
Completed
- Postoperative Complications
- surgery after neoadjuvant chemotherapy
-
Seoul, Korea, Republic ofAsan medical center
Jun 1, 2023
Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)
Recruiting
- Breast Cancer
- Radiotherapy
- SBRT anticipated boost
-
Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna
Jan 9, 2023
Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Pembrolizumab, IO102-103)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
-
Baltimore, MarylandJohns Hopkins University
Aug 2, 2023
Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Xiaopi granules
- +2 more
- (no location specified)
Nov 22, 2023
Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)
Not yet recruiting
- Hepatocellular Carcinoma Resectable
- neoadjuvant therapy
-
Fuzhou, Fujian, ChinaThe First Affiliated Hospital of Fujian Medical University
Aug 19, 2023
Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)
Recruiting
- Melanoma
- Pembrolizumab
- +5 more
-
Los Angeles, California
- +28 more
Jan 25, 2023
Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)
Not yet recruiting
- Female Breast Cancer
- Hormonal Antineoplastics
- Chemotherapy drug
-
Sohag, Egyptamal Ali
Feb 23, 2023
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)
Not yet recruiting
- Breast Cancer
- +2 more
- Dapagliflozin 10mg
-
New Haven, ConnecticutYale Cancer Center Smilow Cancer Hospital
Aug 3, 2023
Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)
Not yet recruiting
- Locally Advanced Hypopharyngeal Carcinoma
- three cycles (toripalimab + cetuximab + platinum)
- +2 more
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 22, 2023
NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Toripalimab
- +2 more
-
Yangzhou, Jiangsu, ChinaPeople's hospital of northern jiangsu
Sep 26, 2023
Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy
Recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- cisplatin based neoadjuvant chemotherapy
- Radical cystectomy alone
-
Rome, ItalyRiccardo Mastroianni
Mar 8, 2023
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023
Colon Cancer Trial (Neoadjuvant chemo)
Not yet recruiting
- Colon Cancer
- Neoadjuvant chemotherapy
- (no location specified)
Oct 25, 2023
Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Short course radiotherapy with concurrent capecitabine(825mg/m2)
- Long course radiotherapy with concurrent capecitabine(825mg/m2)
- (no location specified)
Jun 24, 2023